IB Net Payout Yields Model

Apple: Still Early For The Holy Grail

  •  Apple continues working on turning the Apple Watch into a medical device.
  • The tech giant has made progress on a glucose monitoring system with the signs the concept works, but the company needs to scale the product into a wearable form factor.
  • The stock is already priced for a Holy Grail new product, while investors should buy the stock when a new medical device is a bonus for a cheap stock.
  • Apple shouldn't already trade at 25x FY23 EPS targets.
The holy grail of the Apple (NASDAQ:AAPL) Watch is turning the product into a medical device. The tech company has a promising new use for the watch, but the market has already hyped the entry

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

Celsius: Unaltered Growth Story

Hims & Hers Health: Still Firing On Strong Cylinders